Background and introduction
One of the reasons for performing asthma reviews in practice is to assess the level of disease control, with the aim of adjusting medication to achieve control, in turn to reduce the future risk of exacerbations. Achieving asthma control is one of the major new features in the guidelines produced by The Global Initiative for Asthma (GINA), and reinforced by national asthma guidelines, such as the one developed by the Scottish Intercollegiate Guideline Network with the British Thoracic Society (BTS/SIGN). Another reason for doing these reviews is to also identify and diagnose the existence of co-morbid conditions such as allergic rhinitis, that could affect asthma control.
Co-existent asthma and allergic rhinitis may affect control of asthma, increasing the likelihood of exacerbations and can also impair patients' quality of life. This audit has been commissioned by the international organisation ARIA (Allergic Rhinitis and its Impact on Asthma) and developed utilising the guidelines produced by ARIA, GINA and BTS/SIGN.
Participation in the audit will help primary care health professionals to assess and improve the diagnosis and management of patients with combined asthma and allergic rhinitis in primary care. This audit can be performed by health professionals working from a fixed base, as well as those providing their services on a sessional basis. The system provides instant feedback on attaining set standards and also a report which could form the basis of peer-group discussion, as well as evidence of performing audit for the purposes of professional development, recertification and revalidation.
- Early diagnosis of allergic rhinitis:
- Improve asthma Control and reduce morbidity
- Reduction of symptoms due to allergic rhinitis
- 90% of patients with impaired quality of life due to allergic rhinitis should be treated appropriately
- An occupational cause should be considered in 100% newly diagnosed adults with allergic rhinitis.
- 100% of Patients with uncontrolled asthma and allergic rhinitis should be treated for both conditions
- 90% of Patients with both allergic rhinitis and asthma should be treated for both conditions
- 80% of Patients with Moderate severe allergic rhinitis and uncontrolled asthma should be referred to a specialist